Ad hoc release: PAION grants exclusive license to Mundipharma for development and commercialization of remimazolam in Japan
PAION grants exclusive license to Mundipharma for development and commercialization of remimazolam in Japan
PDF
102 KB
PAION grants exclusive license to Mundipharma for development and commercialization of remimazolam in Japan